Diabetes Technology Society
- Assets
- $1.3m
- Revenue
- $1.2m
- Investments
- $0.0
- Employees
- 7
- Location
- Burlingame, CA
- Founding
- 04/2002
- Data as of
- 12/2022
- EIN
- 30-0012730
Organization Overview
Diabetes Technology Society is located in Burlingame, CA. The organization was established in 2002. According to its NTEE Classification (G80) the organization is classified as: Specifically Named Diseases, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2022, Diabetes Technology Society employed 7 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Diabetes Technology Society is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Diabetes Technology Society generated $1.2m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (6.8%) each year. All expenses for the organization totaled $1.3m during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (6.9%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO FACILITATE RESEARCH INTO THE TREATMENT,MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
TO FURTHER EDUCATE PROFESSIONALS AND THE PUBLIC ON THE TREATMENT, MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES. THIS WAS ACHIEVED BY HOLDING EIGHT EDUCATIONAL VIRTUAL CONFERENCES IN 2022, MAINTAINING AN INFORMATIONAL WEBSITE, AND PUBLISHING 1,585 PAGES OF TECHNICAL ARTICLES ABOUT DIABETES AND DIABETES TECHNOLOGY. CONFERENCES HELD IN 2022 AND THE NUMBER OF ATTENDESS AND OTHER PROJECTS ARE AS FOLLOWS:1. VIRTUAL HOSPITAL DIABETES MEETING (HDM 2022) APRIL 1-2, 2022; 254 ATTENDEES.2. VIRTUAL HOSPITAL DIABETES MEETING POSTER SESSION (HDM POSTER 2022) (FREE VIRTUAL EVENT) APRIL 7, 2022; 56 ATTENDEES.3. CONTINUOUS KETONE MONITORING CONSENSUS PANEL (KETONE CONSENSUS) APRIL 20,2022; 28 ATTENDEES4. UPDATE IN KETONE MONITORING (KETONE 2022)(FREE WEBINAR) OCTOBER 13, 2022; 230 ATTENDEES.5. VIRTUAL DIABETES TECHNOLOGY MEETING (DTM 2022); NOVEMBER 2-5, 2022; 395 ATTENDEES.6. VIRTUAL DIABETES TECHNOLOGY MEETING PRODUCT THEATRE (DTM PRODUCT THEATRE 2022); NOVEMBER 9, 2022; 168 ATTENDEES.7. VIRTUAL DIABETES TECHNOLOGY MEETING POSTER SESSION (DTM POSTER 2022); NOVEMBER 10, 2022; 184 ATTENDEES.8. INTEGRATION OF CONTINUOUS GLUCOSE MONITORING DATA INRO THE ELECTRONIC HEALTH RECORD PROJECT (ICODE 2022) TWENTY-FOUR (24) WORKING GROUP MEETINGS IN THE COURSE OF THE YEAR; THREE (3) VIRTURAL MEETINGS IN 2022. 1/27/22 - 95 ATTENDEES, 6/22/22 - 95 ATTTENDEES, AND 11/2/22 - 82 ATTENDEES
OTHER PROJECTS:DTS PRESENTED: "DETECTION OF HYPOGLYCEMIA USING DATA FROM QUALITATIVE PHYSIOLOGICAL MEASUREMENTS"AT THE INTERNATIONAL HYPOGLYCAEMIA STUDY GROUP (IHSG) ON 11/16/2022.JDST (JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY)PUBLISHED 1,585 PAGES OF TECHNICAL ARTICLES ABOUT DIABETES AND DIABETES TECHNOLOGY- GREEN DIABETES SUMMIT 2021 SUMMARY REPORT - 1/16/22- THE DIABETES TECHNOLOGY SOCIETY GREEN DECLARATION - 1/16/22- IMPROVING THE PATIENT EXPERIENCE WITH LONGER WEAR INFUSION SETS SYMPOSIUM REPORT 2/28/22- A GLYCEMIA RISK INDEX (GRI) OF HYPOGLYCEMIA AND HYPERGLYCEMIA FOR CONTINUOUS GLUCOSE MONITORING VALIDATED BY CLINICIAN RATINGS - 3/29/22- DIABETES TECHNOLOGY MEETING 2021 SUMMARY REPORT - 5/2/22- THE LAUNCH OF THE ICODE STANDARD PROJECT - 5/9/22- TRIMETAZIDINE BLOCKS LIPID OXIDATION-SHOULD IT BE REPURPOSED FOR PREVENTION AND TREATMENT OF DIABETIC KETOACIDOSIS - 6/2/22- RETAINED DIABETES DEVICES-A LITERATURE REVIEW- 7/5/22- USE OF CONTINUOUS GLUCOSE MONITORS BY PEOPLE WITHOUT DIABETES: AN IDEA WHOSE TIME HAS COME? - 7/20/22- HOSPITAL DIABETES MEETING 2022 SUMMARY REPORT - 7/29/22- ICODE JUNE 22, 2022 STEERING COMMITTEE MEETING SUMMARY REPORT - 8/29/22- ARTIFICIAL INTELLIGENCE FOR PREDICTING AND DIAGNOSING COMPLICATIONS OF DIABETES - 9/19/22- TELEHEALTH FATIGUE: IS IT REAL? WHAT SHOULD BE DONE? - 10/7/22- PAINFUL DIABETIC NEUROPATHY: THE NEED FOR NEW APPROACHES - 10/28/22- DETECTION OF HYPOGLYCEMIA AND HYPERGLYCEMIA USING NONINVASIVE WEARABLE SENSORS: ECG AND ACCELEROMETRY - 10/31/22- SPINAL CORD STIMULATION FOR PAINFUL DIABETIC NEUROPATHY - 11/17/22
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Henry Wykowski Director | Trustee | 1 | $0 |
Avery Diamond Director | Trustee | 1 | $0 |
Dr David Klonoff MD President | OfficerTrustee | 40 | $0 |
Dr Gerald R Sydorak MD Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $738,153 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $738,153 |
| Total Program Service Revenue | $418,745 |
| Investment income | $7,048 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,163,946 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $607,813 |
| Compensation of current officers, directors, key employees. | $60,781 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $190,418 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $35,532 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $7,448 |
| Fees for services: Accounting | $3,005 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $298,415 |
| Advertising and promotion | $0 |
| Office expenses | $5,578 |
| Information technology | $12,938 |
| Royalties | $0 |
| Occupancy | $20,400 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $4,879 |
| Insurance | $19,976 |
| All other expenses | $17,175 |
| Total functional expenses | $1,267,548 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $1,330,379 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $1,488 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $2,721 |
| Other assets | $0 |
| Total assets | $1,334,588 |
| Accounts payable and accrued expenses | $11,118 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $11,118 |
| Net assets without donor restrictions | $1,323,470 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,334,588 |